Registered entities
IMMUNOMOLECULAR THERAPEUTICS, INC.
Reg. No. 47-2787642United States
Innovation
7 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 680 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Investor mix
6 investors on record; lead investors include T1D Fund, Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |